Jan 16, 2025 · Importantly, key markers of bone turnover increased in the all-placebo group at 5 years, whereas the measures decreased by approximately 30%-40% in each of the zoledronate groups.

Jan 13, 2025 · Dr. Kevin Fernando discusses the diagnosis and management of subclinical hyperthyroidism, which entails increased cardiovascular and orthopedic risk, in primary care.

Feb 4, 2025 · Last month, the US Food and Drug Administration (FDA) approved two new drugs, expanded the indications for several other agents as well as a diagnostic test, and issued a clinical trial hold on a ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.

Jan 16, 2025 · As evidence accumulates on the protective effects of a plant-heavy diet against cancers, experts explain how providers can incorporate those findings into routine medical visits.

Jan 22, 2025 · Big data show surprising outcomes of GLP-1 receptor agonist therapy. Dr F. Perry Wilson comments.

Jan 6, 2025 · Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle closure, a recent study found.

Jan 31, 2025 · Another challenge in the artificial muscle field is getting the materials to work with something like bone. “Muscle is meant to pull on tendons, which allow muscle to transmit the force that it ...

Dec 18, 2024 · Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side effects — especially muscle loss.

Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.